文献库搜索 | GeneLibs

Chen(MY),Zhou(JL),Zhang(XY),Zhai(QZ),Li(MX... Zhonghua Zhong Liu Za Zhi 2026-07-23

...BRCA1/2 genes through genetic testing were selected. According to the test results, they were divided into the BRCA1 mut...

Li(NM),Cheng(HP),Zhou(P),Li(XH) Zhonghua Zhong Liu Za Zhi 2026-07-23

...BRCA1/2 and other genes, HRD scores, MSI, and TMB. HRD positivity was defined as the presence of a BRCA1/2 pathogenic/li...

El-Deiry(WS),Hernando-Calvo(A),Dizon(D),Ma... Oncotarget 2026-07-21

...BRCA1 germline mutation who developed multiple primary cancers: breast, skin, high-grade serous carcinoma of the ovary, ...

Valle(LF),Scobie(M),Rowe(K),Pritchard(CC),... Oncologist 2026-07-08

...BRCA1 variants which were more frequently identified in tests with CH interference (2.0% vs 0%, P = .02). In samples wit...

Ahmadipour(M),Bhattacharya(A),Ahmadipour(M... Crit Rev Biotechnol 2026-09-00

...BRCA1, and MUC1, including performance metrics such as linear range, limit of detection (LOD), and sensitivity. Addition...

Koyama(K),Tsukita(H),Ishinari(T),Takahashi... Pathol Int 2026-07-00

...BRCA1/2 mutation carriers using the sectioning and extensively examining the fimbriated end protocol and performed immun...

Tooming(M),Rekker(K),Toome(K),Roht(L),Laid... Front Genet None

Genetic testing for likely pathogenic/pathogenic variants (PV) in BRCA1, BRCA2, and other cancer-associated genes plays ...

Dong(M),Hua(J),Ma(Z),Tang(R),Wei(M),Lv(Z),... Cancer Med 2026-07-00

...BRCA1/2 and PALB2 mutations showed a trend towards improved survival with platinum-containing regimens, although statist...

Wu(Y),Yang(G),Li(Y),Ruan(Y),Yang(Q) Front Oncol None

...BRCA1, TGFB1, TUBA1B, XRCC1, PTGS2, IL7, and TUBB2B were screened as prognostic genes for BC. The constructed RSF model ...

Domènech(H),Simonetti(S),Romero-Lozano(P),... NPJ Precis Oncol 2026-07-11

...BRCA1/BRCA2 reversion mutations in >30% of post-PARPi mBC samples, which were associated with poor response to subsequen...